Russian government sets out new restrictions for foreign drugmakers in state tenders

The Russian government has designed new restrictions for the participation of foreign drugmakers in state tenders for the purchase of drugs for state needs, reports The Pharma Letter’s local correspondent.

According to the proposal of the Russian Ministry of Industry and Trade, an absolute advantage during state tenders for public procurement of drugs will be provided to those companies which use Russian-made substances/active ingredients in the production of drugs within Russia.

An official spokesman for Russian Health Minister Veronika Skvortsova said that, under the “Russian substance” rule, the legislation will mean those raw materials from which the molecule synthesis step has been carried out i Choosen Russia.